An interventional prospective study to evaluate and compare the efficacy of the combination of Fractional CO2 Laser (FCL) and Intralesional Triple therapy (ILS-3) against Intralesional Triple Therapy (ILS-3) alone in the treatment of keloids.

This study is a randomized, open lable, parallel group, single centre trial evaluating and comparing the efficacy of the combination of Fractional CO2 Laser and Intralesional triple therapy against Intralesional triple therapy alone in the treatment of keloids. the primary outcome measures regression in the size of keloids every 3 weeks for first 4 sessions, followed by at 3rd and 6th month. the secondary outcome measures the regression in the symptoms associated with keloids viz. pain and pruritus from the second session.